Prevalence of lung cancer in patients with interstitial lung disease is higher than in those with chronic obstructive pulmonary disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Hye In | - |
dc.contributor.author | Park, Jae Seok | - |
dc.contributor.author | Lee, Mi-Young | - |
dc.contributor.author | Park, ByeongJu | - |
dc.contributor.author | Kim, Hyun Jung | - |
dc.contributor.author | Park, Sun Hyo | - |
dc.contributor.author | Choi, Wonil | - |
dc.contributor.author | Lee, Choong Won | - |
dc.date.accessioned | 2023-09-18T07:21:05Z | - |
dc.date.available | 2023-09-18T07:21:05Z | - |
dc.date.created | 2023-07-07 | - |
dc.date.issued | 2018-03 | - |
dc.identifier.issn | 0025-7974 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/190983 | - |
dc.description.abstract | We aimed to explore lung cancer prevalence in interstitial lung disease (ILD) patients with or without connective tissue disorder (CTD) and idiopathic pulmonary fibrosis (IPF) in comparison with chronic obstructive pulmonary disorder (COPD).We evaluated lung cancer prevalence associated with ILD and IPF using Korean Health Insurance Review and Assessment Service (HIRA) data from January to December 2011. This database (HIRA-NPS-2011-0001) was sampled using random sampling of outpatients; 1,375,842 sample cases were collected, and 670,258 (age 40 ys) were evaluated. Patients with ILDs, IPF, CTD, or COPD were identified using the International Classification of Disease-10 diagnostic codes.Lung cancer prevalence rates per 100,000 persons for the sample population and those with ILD, IPF, CTD-ILD, and COPD were 420, 7334, 7404, 7272, and 4721, respectively. Lung cancer prevalence was significantly higher in those with ILD than in those with COPD (P<.01).More attention should be paid to lung cancer development in those with ILD as well as COPD. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS &amp; WILKINS | - |
dc.title | Prevalence of lung cancer in patients with interstitial lung disease is higher than in those with chronic obstructive pulmonary disease | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Wonil | - |
dc.identifier.doi | 10.1097/MD.0000000000010071 | - |
dc.identifier.scopusid | 2-s2.0-85044038858 | - |
dc.identifier.wosid | 000427995300003 | - |
dc.identifier.bibliographicCitation | MEDICINE, v.97, no.11, pp.1 - 5 | - |
dc.relation.isPartOf | MEDICINE | - |
dc.citation.title | MEDICINE | - |
dc.citation.volume | 97 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 5 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | SYSTEMIC-LUPUS-ERYTHEMATOSUS | - |
dc.subject.keywordPlus | POPULATION-BASED COHORT | - |
dc.subject.keywordPlus | CRYPTOGENIC FIBROSING ALVEOLITIS | - |
dc.subject.keywordPlus | RHEUMATOID-ARTHRITIS | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | KOREA | - |
dc.subject.keywordPlus | MALIGNANCY | - |
dc.subject.keywordPlus | DERMATOMYOSITIS | - |
dc.subject.keywordPlus | POLYMYOSITIS | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordAuthor | interstitial lung disease | - |
dc.subject.keywordAuthor | lung cancer | - |
dc.subject.keywordAuthor | prevalence | - |
dc.identifier.url | https://journals.lww.com/md-journal/fulltext/2018/03160/prevalence_of_lung_cancer_in_patients_with.3.aspx | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.